Mary‐Jane Guerry

883 total citations
10 papers, 570 citations indexed

About

Mary‐Jane Guerry is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, Mary‐Jane Guerry has authored 10 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Genetics. Recurrent topics in Mary‐Jane Guerry's work include Vasculitis and related conditions (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Chronic Lymphocytic Leukemia Research (1 paper). Mary‐Jane Guerry is often cited by papers focused on Vasculitis and related conditions (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Chronic Lymphocytic Leukemia Research (1 paper). Mary‐Jane Guerry collaborates with scholars based in France, United Kingdom and Spain. Mary‐Jane Guerry's co-authors include David Jayne, Rona Smith, Fausta Catapano, Afzal Chaudhry, Rachel Jones, Kenneth G. C. Smith, Saad Nseir, Simona Laurino, Julien Poissy and Daniel Mathieu and has published in prestigious journals such as BMJ, Lara D. Veeken and Shock.

In The Last Decade

Mary‐Jane Guerry

10 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary‐Jane Guerry France	7	292	148	136	115	101	10	570
Leïla Tricot France	15	136 0.5×	72 0.5×	52 0.4×	98 0.9×	32 0.3×	19	750
José Valverde Spain	12	388 1.3×	309 2.1×	74 0.5×	41 0.4×	19 0.2×	32	673
J.L. Dupond France	12	132 0.5×	108 0.7×	35 0.3×	48 0.4×	39 0.4×	52	455
Jonathan Akikusa Australia	16	173 0.6×	175 1.2×	48 0.4×	134 1.2×	9 0.1×	44	834
Nadia Mehsen France	9	41 0.1×	54 0.4×	87 0.6×	46 0.4×	218 2.2×	18	967
K. Stankovic France	13	88 0.3×	50 0.3×	259 1.9×	36 0.3×	17 0.2×	36	538
D. Blockmans Belgium	5	215 0.7×	168 1.1×	73 0.5×	15 0.1×	318 3.1×	6	547
Laurent Pérard France	16	248 0.8×	214 1.4×	63 0.5×	102 0.9×	5 0.0×	34	823
X Tena Spain	13	72 0.2×	478 3.2×	48 0.4×	70 0.6×	74 0.7×	38	868
Federica Vanoni Switzerland	15	112 0.4×	166 1.1×	10 0.1×	169 1.5×	34 0.3×	31	650

Countries citing papers authored by Mary‐Jane Guerry

Since Specialization

Citations

This map shows the geographic impact of Mary‐Jane Guerry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Jane Guerry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Jane Guerry more than expected).

Fields of papers citing papers by Mary‐Jane Guerry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary‐Jane Guerry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Jane Guerry. The network helps show where Mary‐Jane Guerry may publish in the future.

Co-authorship network of co-authors of Mary‐Jane Guerry

This figure shows the co-authorship network connecting the top 25 collaborators of Mary‐Jane Guerry. A scholar is included among the top collaborators of Mary‐Jane Guerry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary‐Jane Guerry. Mary‐Jane Guerry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Gouellec, N. Le, et al.. (2017). Acidose pyroglutamique au paracétamol : une cause méconnue d’acidose métabolique à trou anionique élevé. Néphrologie & Thérapeutique. 13(5). 387–388. 1 indexed citations

Marco, Helena, Rona Smith, Rachel Jones, et al.. (2014). The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease. BMC Musculoskeletal Disorders. 15(1). 178–178. 110 indexed citations

Favory, Raphaël, Julien Poissy, Mary‐Jane Guerry, et al.. (2013). Activated Protein C Improves Macrovascular and Microvascular Reactivity in Human Severe Sepsis and Septic Shock. Shock. 40(6). 512–518. 8 indexed citations

Parmentier-Decrucq, Erika, Julien Poissy, Raphaël Favory, et al.. (2013). Adverse events during intrahospital transport of critically ill patients: incidence and risk factors. Annals of Intensive Care. 3(1). 10–10. 154 indexed citations

Hot, A., Mary‐Jane Guerry, Rona Smith, et al.. (2013). A multicenter survey of rituximab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss). La Presse Médicale. 42(4). 698–698. 4 indexed citations

Smith, Rona, Rachel Jones, Mary‐Jane Guerry, et al.. (2012). Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis & Rheumatism. 64(11). 3760–3769. 176 indexed citations

Guerry, Mary‐Jane & Malcolm Lemyze. (2012). Acute skin failure. BMJ. 345(aug06 1). e5028–e5028. 1 indexed citations

Willekens, Christophe, et al.. (2011). Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case report. Journal of Medical Case Reports. 5(1). 280–280. 16 indexed citations

Blazejewski, Caroline, et al.. (2011). New Methods to Clean ICU Rooms. Infectious Disorders - Drug Targets. 11(4). 365–375. 19 indexed citations

10.

Guerry, Mary‐Jane, Paul Brogan, Ian N Bruce, et al.. (2011). Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Lara D. Veeken. 51(4). 634–643. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact